Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

GenSight Biologics S. A., a clinical-stage biotechnology company, discovers, develops, and commercializes therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms.

Similar securities

Based on sector and market capitalization

Report issue